MODERATE TO SEVERE GLABELLAR LINES
Clinical trials for MODERATE TO SEVERE GLABELLAR LINES explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE GLABELLAR LINES trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE GLABELLAR LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New wrinkle treatment aims to erase frown lines in one shot
Symptom relief Recruiting nowThis study tests a single injection of IPN10200 to improve moderate to severe frown lines between the eyebrows in adults. About 300 participants will receive either the study drug or a placebo, and their results will be tracked for up to 55 weeks. The goal is to see if the treatm…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated May 26, 2026 07:40 UTC
-
New injection aims to smooth away frown lines in large trial
Symptom relief Recruiting nowThis study tests a single dose of IPN10200, an injectable treatment, to see if it safely reduces moderate to severe frown lines (glabellar lines) in adults. About 1,300 participants will receive either the treatment or a placebo, and some may get repeat doses over time. The goal …
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated May 26, 2026 07:35 UTC
-
New wrinkle treatment eveotox takes on botox in major trial
Symptom relief Recruiting nowThis study tests a new injection called Eveotox for moderate to severe frown lines between the eyebrows. About 669 adults aged 18 to 65 will receive either Eveotox, Botox, or a placebo to see how well it smooths wrinkles and if it is safe. The goal is to offer another option for …
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated May 26, 2026 07:25 UTC